GlassScriptPhysician profile
Candice Jinhee Kim
NPI 1942568852
$4,394.90
in general payments reported to CMS, 2019-2025
37 companies · $645 in 2025
The $645 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,000 · 2020: $150 · 2021: $573 · 2022: $646 · 2023: $851 · 2024: $530 · 2025: $645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,026.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,026.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $808.41 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $348.89 | 2019-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $306.36 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $304.08 | 2019-2025 | Farxiga |
| Pfizer INC. | $291.65 | 2019-2025 | |
| Abbott Laboratories | $265.67 | 2021-2025 | Mitraclip, Jot Dx |
| Amgen INC. | $251.41 | 2019-2025 | Repatha |
| Merck Sharp & Dohme LLC | $196.34 | 2021-2025 | Verquvo |
| Novo Nordisk INC | $185.58 | 2024-2025 | Ozempic, Wegovy |
| Janssen Pharmaceuticals, INC | $181.87 | 2019-2023 | Xarelto |
| Regeneron Healthcare Solutions, INC. | $111.60 | 2019-2025 | Evkeeza |
| Kiniksa Pharmaceuticals International, Plc | $110.71 | 2024 | Arcalyst |
| Inspire Medical Systems, INC. | $103.79 | 2025 | Inspire |
| Medtronic Vascular, INC. | $94.69 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $82.18 | 2019-2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $80.00 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Lexicon Pharmaceuticals, INC. | $71.44 | 2023-2024 | Inpefa |
| Boston Scientific Corporation | $68.33 | 2022-2023 | Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $60.92 | 2019-2022 | |
| Biotronik INC. | $52.54 | 2021-2025 | Biomonitor |
| Scpharmaceuticals INC. | $52.21 | 2023-2024 | |
| Abiomed | $37.20 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $36.39 | 2023 | Uptravi |
| Amarin Pharma, INC. | $29.15 | 2019 | |
| Kestra Medical Technology Services, INC. | $28.91 | 2025 | Assure Wcd |
| Biosense Webster, INC. | $28.89 | 2022 | |
| Daiichi Sankyo INC. | $25.40 | 2023 | Injectafer |
| Chiesi USA, INC. | $25.09 | 2023 | Kengreal |
| Edwards Lifesciences Corporation | $24.58 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Itamar Medical INC | $21.39 | 2022 | |
| Averitas Pharma INC. | $19.84 | 2023 | Qutenza |
| Arbor Pharmaceuticals, INC. | $17.07 | 2019 | |
| Cordis US Corp. | $16.41 | 2022 | |
| Philips North America LLC | $15.89 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Bayer Healthcare Pharmaceuticals INC. | $14.24 | 2025 | |
| W. L. Gore & Associates, INC. | $13.90 | 2023 | Gore Cardioform Septal Occluder |
| Kowa Pharmaceuticals America, INC. | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candice Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.